Sign In
Buy VKTX
$32.37
+1.99 (+6.55%)
At Close: Jun 22, 2026
Stock Picks From Seeking Alpha's February 2025 New Analysts
03:30pm, Thursday, 06'th Mar 2025
In February, twenty-three new analysts joined Seeking Alpha, offering diverse stock picks and insights, from biotech to automotive and energy sectors. Analysts provided ratings from Strong Sell to Str
Viking Therapeutics to Participate at Upcoming Investor Conferences
04:05pm, Tuesday, 04'th Mar 2025
SAN DIEGO , March 4, 2025 /PRNewswire/ -- Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic a
Viking Therapeutics, Inc. (VKTX) Ascends But Remains Behind Market: Some Facts to Note
06:51pm, Friday, 28'th Feb 2025
In the closing of the recent trading day, Viking Therapeutics, Inc. (VKTX) stood at $28.87, denoting a +0.7% change from the preceding trading day.
1 Biotech Stock to Buy in 2025, and 1 to Avoid
08:00am, Friday, 28'th Feb 2025
Viking Therapeutics (VKTX 3.06%) and Novavax (NVAX -3.55%) were two of the big winners in the biotech industry last year. Both companies saw their shares rise significantly; the former had exciting cl
3 Beaten-Down Biotech Stocks to Buy Before They Soar. Wall Street Is Predicting Jumps of 68% to 250%.
03:15am, Friday, 28'th Feb 2025
Investors looking for growth in recent times have piled into stocks in artificial intelligence and quantum computing. But these aren't the only areas that offer the potential for explosive revenue gro
Viking Therapeutics: Could GLP-1 Maker Be Acquired Pre-Approval?
07:50am, Wednesday, 26'th Feb 2025
The GLP-1 industry is currently an oligopoly ruled by two pharmaceutical giants, Novo Nordisk A/S NYSE: NVO, maker of semaglutide under the Ozempic and Wegovy name brands, and Eli Lilly & Co. NYSE: L
Is Viking Therapeutics a Buy Right Now?
04:20am, Wednesday, 26'th Feb 2025
Viking Therapeutics (VKTX -3.01%) soared into the spotlight about a year ago when it delivered promising data on a drug candidate that aims to compete in an area of very high demand: weight loss. The
Viking Therapeutics: Development Of VK2735 Continues, Buyout Or Not
08:16pm, Monday, 24'th Feb 2025
Viking Therapeutics: Development Of VK2735 Continues, Buyout Or Not
Should You Buy VKTX Stock Amid Renewed M&A Speculations?
10:45am, Monday, 24'th Feb 2025
Given the optimism around its obesity candidate, we believe investors should stay invested in Viking Therapeutics, regardless of buyout speculations.
Few big pharma stocks have been bigger winners over the last three years than Eli Lilly and Novo Nordisk. Lilly now ranks as the largest drugmaker in the world, with a market cap of $844 billion, afte
3 Weight-Loss Drug Stocks to Watch
12:36pm, Thursday, 13'th Feb 2025
Weight-loss drugs have been popular over the past couple of years, and Hims & Hers Health Inc (NYSE:HIMS), Novo Nordisk A/S ( NYSE:NVO) , and Viking Therapeutics Inc (NASDAQ:VKTX) are among the
2 Stocks to Buy With Less Than $40
09:00am, Monday, 10'th Feb 2025
Some think investing in stocks requires substantial start-up capital, but that's false. Even with a modest sum, like $40, investors can acquire shares of companies whose long-term prospects look excit
3 No-Brainer Healthcare Stocks to Buy With $200 Right Now
04:20am, Monday, 10'th Feb 2025
Healthcare stocks have something to offer every investor. If you're looking for high growth, you can try an innovative biotech that may launch game-changing products down the road.
2 Stocks That Could Soar Again in 2025
08:50am, Saturday, 08'th Feb 2025
Many companies in the biotech industry performed well last year. Two in particular stood out: Viking Therapeutics (VKTX 3.50%) and Summit Therapeutics (SMMT -2.71%).
Down 65%, Is Viking Therapeutics Stock a Buy on the Dip?
03:57am, Saturday, 08'th Feb 2025
Nearly a year ago, Viking Therapeutics (VKTX 3.50%) shares exploded higher after the clinical-stage drugmaker announced successful results from a clinical trial with an experimental weight loss drug.
